KMT2D and cancer: Similarly, an analysis of the genomic landscape of MSI-H in 11,395 tumors across 30 cancer types showed that mutations in ACVR2A (73%), KMT2D (68%), KMT2B (66%), and MMR-related genes were enriched in the MSI-H group [52].